Imatinib Sensitivity in BCR-ABL1–Positive Chronic Myeloid Leukemia Cells Is Regulated by the Remaining Normal ABL1 Allele-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Imatinib Sensitivity in BCR-ABL1–Positive Chronic Myeloid Leukemia Cells Is Regulated by the Remaining Normal ABL1 Allele

Published:2011-06-21 Issue:16 Volume:71 Page:5381-5386
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Virgili Anna,Koptyra Mateusz,Dasgupta Yashodhara,Glodkowska-Mrowka Eliza,Stoklosa Tomasz,Nacheva Elisabeth P.,Skorski Tomasz

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imatinib prevents dexamethasone‐induced pancreatic β‐cell apoptosis via decreased TRAIL and DR5;Journal of Cellular Biochemistry;2023-08-09

2. MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemia;Leukemia;2023-06-29

3. In silico analysis of alternative splicing on drug-target gene interactions;Scientific Reports;2020-01-10

4. The emergence of drug resistance to targeted cancer therapies: Clinical evidence;Drug Resistance Updates;2019-12

5. Imatinib-Induced Changes in Protein Expression and ATP-Binding Affinities of Kinases in Chronic Myelocytic Leukemia Cells;Analytical Chemistry;2019-02-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP